-
Combining Mass Spectrometry with Genetic and Pharmacological Approaches to Discover and Validate LRRK2 Substrates
… this condition. Our objective is to deploy the state of the art molecular, technological, genetic and clinical expertise … and undertake detailed analysis using state of the art technology called mass spectrometry to identify sets of … … United States … LRRK2 … LRRK2 Biology LEAPS … Jarrod A. Marto, PhD … Nicholas William Wood, MbChB, PhD, FRCP, FMedSci …
-
Gregory Petsko, DPhil
… the Institute of Medicine, the American Academy of Arts and Sciences and the American Philosophical Society. …
-
W. Jeffrey Elias, MD
… Wake Forest University, where he received a Bachelor of Arts degree and was awarded a scholarship for undergraduate …
-
Kevan M. Shokat, PhD
… Academy of Medicine (2011), and the American Academy of Arts and Sciences (2011). He has commercialized discoveries …
-
Anne B. Young, MD, PhD
… both the Institute of Medicine and the American Academy of Arts and Sciences. Dr. Young's current research work …
-
Pietro De Camilli, MD
… National Academy of Medicine and the American Academy of Arts and Sciences. De Camilli’s lab investigates mechanisms …